Mo1955 – Ve303, a Live Biotherapeutic Product for Prevention of Recurrent Clostridioides Difficile (C. Difficile) Infection. Preliminary Results of a Phase 1, Open-Label Healthy Volunteers Study of Oral Ve303 After Vancomycin

Autor:	Lou Vaickus, Dmitri Bobilev, Paolo DePetrillo, Jason M. Norman, Shilpa Reddy, Brian Klein, Bernat Olle, Bruce L. Roberts
Rok vydání:	2019
Předmět:	medicine.medical_specialty Hepatology business.industry Gastroenterology C difficile Internal medicine Product (mathematics) Healthy volunteers medicine Vancomycin Open label business Clostridioides medicine.drug
Zdroj:	Gastroenterology. 156:S-899
ISSN:	0016-5085
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::38b2d92183c93940f7825203c59f8cdd https://doi.org/10.1016/s0016-5085(19)39218-2 Zobrazit plný text záznamu